GeoVax Reports 2021 Year-End Financial Results and Provides

Advancing Phase 2 Clinical Trials for COVID-19 and Immuno-Oncology  ATLANTA, GA, March 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax...

Related Keywords

,National Cancer Institute ,Emory University ,Drug Administration ,Nasdaq ,Geovax Labs Inc ,Therapeutics Inc ,Products Clinical Trials Grants Program ,Stanford University ,Advancing Phase ,Geovax Labs ,Standard Time ,Trials Underway ,Immunocompromised Patients ,Booster Vaccine ,Enabling Activities Progressing ,Japan Coronavirus Vaccine ,Trial Underway ,Advanced Head ,Gene Directed Enzyme Prodrug Therapy ,Orphan Products Clinical Trials Grants ,Nasdaq Govx ,Geovax ,Nc ,